logo

For the Inventor, By the Inventor

Kaohsiung, Taiwan

Ing-Jun Chen

This inventor holds 16 USPTO granted patents and 21 published patent applications. Top assignees: National Science Council, Kaohsiung Medical University, Cho-Jan Liang. Active years: 1993-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ing-Jun Chen. Retrieved from https://idiyas.com/inventor/ing-jun-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 56.3

Average Co-Inventor Count = 1.1

ph-index = 3

Forward Citations = 43(Granted Patents)


Company Filing History:

goldMedal4 out of 544 
 
National Science Council
 patents
silverMedal3 out of 147 
 
Kaohsiung Medical University
 patents
bronzeMedal1 out of 1 
 
Cho-Jan Liang
 patent
4. 1 out of 1 
 
Ing-Jun Chen
 patent
5. 1 out of 1 
 
Syn-Rech Chem & Phan Co., Ltd
 patent
6. 1 out of 5 
 
Syn-Tech Chem. & Pharm. Co., Ltd.
 patents
7. 1 out of 1 
 
Tong-Ho Lin
 patent
8. 6 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2013

Loading Chart...
16 patents (USPTO):Explore Patents
1. 8507506 - Theophylline derivative inhibits osteoporosis (2013-08-13),
2. 8497370 - Processes for preparing amine salts of sildenafil-analogues and use thereof (2013-07-30),
3. 8470805 - Processes for preparing piperazinium salts of KMUP and use thereof (2013-06-25),
4. 7550468 - Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase (2009-06-23),
5. 7105521 - Eugenosedin-A based pharmacoligical agents (2006-09-12),
6. 6979687 - Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities (2005-12-27),
7. 6887878 - KMST isoeugenol derivatives and pharmaceutical activity (2005-05-03),
8. 6846826 - Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain (2005-01-25),
9. 6794399 - 1,4-dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety (2004-09-21),
10. 6518450 - Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity (2003-02-11),
11. 5939578 - Vasomolol: an ultra short-acting and vasodilatory vanilloid type (1999-08-17),
12. 5840720 - 4-O and 5-aminomethylation of synthetic capsaicin derivatives, a new (1998-11-24),
13. 5804603 - Synthesized .beta.-adrenergic blockers derivatives of guaiacol (1998-09-08),
14. 5744468 - Hypotensive intraocular pressure activity of clozapine and sulpiride (1998-04-28),
15. 5495005 - Synthesis and pharmacological activity of a series of novel xanthone (1996-02-27),

Title: Ing-Jun Chen: Innovator in Pharmaceutical Patents

Introduction

Ing-Jun Chen is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work focuses on innovative solutions that address critical health issues, particularly in the area of osteoporosis and drug formulations.

Latest Patents

Among his latest patents is a theophylline derivative that inhibits osteoporosis. This invention is characterized by its pharmaceutical functions that protect against bone resorption and inflammatory mediator infiltration. Another notable patent involves processes for preparing amine salts of sildenafil analogues. This series of amine salts includes specific structures that are defined in the patent specification, showcasing their potential as pro-drug active forms with various pharmaceutical functions.

Career Highlights

Ing-Jun Chen has worked with reputable organizations, including the National Science Council. His career is marked by a commitment to advancing pharmaceutical research and development, contributing to innovative solutions that improve health outcomes.

Collaborations

Throughout his career, Ing-Jun Chen has collaborated with notable colleagues, including Tong-Ho Lin and Chun-Nan Lin. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Ing-Jun Chen's contributions to pharmaceutical innovations demonstrate his dedication to improving health through scientific advancements. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…